Astrana Health, Inc.: 10-K filed 2012-05-15
What Astrana Health, Inc. reported in its annual report filed 2012-05-15 (fiscal FY 2011): 29 published measures, 58 facts as tagged in accession 0001144204-12-029578.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-05-15
- Fiscal period
- fiscal FY 2011
- Accession
- 0001144204-12-029578 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Astrana Health, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 1,364,048 | USD | |
| At 2011-01-31 | 1,258,139 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 1,785,268 | USD | |
| At 2011-01-31 | 1,341,333 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | -659,321 | USD | |
| At 2011-01-31 | -311,309 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 164,361 | USD | |
| At 2011-01-31 | 397,101 | USD | |
| At 2010-01-31 | 665,737 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | -720,346 | USD | 365 |
| 2010-02-01 to 2011-01-31 | -156,331 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | -385,455 | USD | 365 |
| 2010-02-01 to 2011-01-31 | -245,031 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | 7,205 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 21,165 | USD | 365 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | 5,110,806 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 3,896,584 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | -4,290 | USD | 365 |
| 2010-02-01 to 2011-01-31 | -2,440 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | 157,005 | USD | 365 |
| 2010-02-01 to 2011-01-31 | -21,165 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | -2,117,708 | USD | |
| At 2011-01-31 | -1,397,363 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | 5,819 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 1,600 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 43,261 | USD | |
| At 2011-01-31 | 21,593 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | -413,335 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 4,015 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 1,249,224 | USD | |
| At 2011-01-31 | 1,197,483 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | 131,534 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 126,431 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 1,515,268 | USD | |
| At 2011-01-31 | 92,745 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 32,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 38,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 994,118 | USD | |
| At 2011-01-31 | 704,971 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | 1,391,742 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 577,847 | USD | 365 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | 978,407 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 581,862 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 29,335,774 | shares | |
| At 2011-01-31 | 27,635,774 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | 1,429,051 | USD | |
| At 2011-01-31 | 1,058,418 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-01-31 | -421,220 | USD | |
| At 2011-01-31 | -83,194 | USD | |
| At 2010-01-31 | -46,393 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | 1,379,153 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 566,649 | USD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | 12,589 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 11,198 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | -301,192 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 158,746 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-02-01 to 2012-01-31 | 407,224 | USD | 365 |
| 2010-02-01 to 2011-01-31 | 290,363 | USD | 365 |
Inspect the source
- Entity
- Astrana Health, Inc. / CIK 0001083446
- Captured
- SEC response SHA-256
24589a8b90ad6a7cdaab8fd1b252b61b042f4e45ec87312920857f7a3d1d7dfe
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001083446.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))